Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:08 AM
Ignite Modification Date:
2025-12-25 @ 2:08 AM
NCT ID:
NCT01938560
Eligibility Criteria:
Inclusion Criteria:
* Able to read, speak, and understand English.
* Willing to take the online survey or have the survey administered via a telephone interview, including electronically signing a Confidentiality \& Consent agreement and completing all study protocol-specified procedures.
* Prescribed retigabine within the past 12 months (prescribing physicians)
* Filled a prescription for at least one AED within the previous three months (pharmacists).
Exclusion Criteria:
* Physicians or pharmacists meeting any of the following criteria will not be eligible to take the survey:
* The physician or pharmacist is currently employed by, or is a representative of any of the following:
* A pharmaceutical company or manufacturer of medicines or healthcare products.
* Contributor/editor to published guideline committees for epilepsy or UR.
* The physician or pharmacist has a visual impairment that would prevent him or her from being able to read independently.
* The physician or pharmacist participated in the Pilot REMS study for retigabine.
* The physician or pharmacist is an employee of GSK or Concentrics Research.
Healthy Volunteers:
True
Sex:
ALL
Study:
NCT01938560
Study Brief:
Protocol Section:
NCT01938560